The Dow Jones Industrial Average closed at 30,216.45 on Monday with a gain of 37.40 points or 0.12%. The S&P 500 closed at 3,694.92 for a loss of 14.49 points or -0.39%. The Nasdaq Composite closed at 12,742.52 for a loss of 13.12 points or -0.10%. The VIX Volatility Index was higher at 25.16 for a gain of 3.59 points or 16.64%.
Monday's Market Movers
U.S. stocks ended mostly lower Monday. Investors were concerned about reports of a new Coronavirus strain in the UK. Over the weekend, Moderna's (MRNA, Financial) Covid-19 vaccine was cleared for emergency use. Pfizer's (PFE, Financial) vaccine has been approved for use in the European Union.
In other news:
- Financials led gains for the day
- Several banks announced buyback plans after the Fed loosened restrictions
- Goldman Sachs (GS, Financial) was up 6.07%
- The Chicago Fed National Activity Index decreased to 0.27 in November from 1.01
- The Treasury held auctions for three-month bills at a rate of 0.090% , six-month bills at a rate of 0.090% and 20-year bonds at a rate of 1.470%
- Anterix (ATEX, Financial) gained 49.10%
Small-Cap Stocks
In small-caps, the Russell 2000 closed at 1,970.33 for a gain of 0.34 points or 0.017%. The S&P 600 closed at 1,104.60 for a loss of 3.56 points or -0.32%. The Dow Jones U.S. Small-Cap Growth Index closed at 13,829.08 for a gain of 64.34 points or 0.47%. The Dow Jones U.S. Small-Cap Value Index closed at 8,887.53 for a loss of 52.39 points or -0.59%.
Other Notable Indexes
Other notable index closes included the S&P 400 Mid-Cap Index at 2,282.18 for a loss of 5.08 points or -0.22%; the S&P 100 at 1,693.02 for a loss of 2.70 points or -0.16%; the Nasdaq 100 at 12,690.26 for a loss of 47.92 points or -0.38%; the Russell 3000 at 2,220.10 for a loss of 6.91 points or -0.31%; the Russell 1000 at 2,092.62 for a loss of 6.99 points or -0.33%; the Wilshire 5000 at 38,693.03 for a loss of 112.70 points or -0.29%; and the Dow Jones U.S. Select Dividend Index at 675.75 for a loss of 5.75 points or -0.84%.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.